|
1
|
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
|
Oncogene
|
2007
|
1.85
|
|
2
|
Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
|
Mol Med
|
1998
|
1.06
|
|
3
|
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.
|
Cell Death Differ
|
2013
|
1.06
|
|
4
|
Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression.
|
Am J Pathol
|
1998
|
1.04
|
|
5
|
Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis.
|
Hum Pathol
|
1999
|
0.95
|
|
6
|
Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
|
J Pathol
|
2007
|
0.91
|
|
7
|
E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
|
J Clin Pathol
|
2007
|
0.90
|
|
8
|
Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
|
Mol Med
|
2000
|
0.88
|
|
9
|
Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
|
J Pathol
|
2001
|
0.87
|
|
10
|
Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data.
|
Eur J Vasc Endovasc Surg
|
2006
|
0.85
|
|
11
|
Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
|
Cancer Res
|
2001
|
0.84
|
|
12
|
Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.
|
Mutat Res
|
2004
|
0.84
|
|
13
|
Expression of p16(INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status.
|
Int J Cancer
|
2000
|
0.84
|
|
14
|
Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
|
Anticancer Res
|
1999
|
0.82
|
|
15
|
Ras oncogene activation in benign and malignant colorectal tumours.
|
Tumori
|
1995
|
0.81
|
|
16
|
Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
|
Br J Cancer
|
1998
|
0.81
|
|
17
|
Low levels of p27 in association with deregulated p53-pRb protein status enhance tumor proliferation and chromosomal instability in non-small cell lung carcinomas.
|
Mol Med
|
2001
|
0.80
|
|
18
|
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
|
Cancer
|
2000
|
0.79
|
|
19
|
Response of human immunodeficiency virus long terminal repeat to growth factors and hormones.
|
Anticancer Res
|
1990
|
0.79
|
|
20
|
Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
|
Anticancer Res
|
1999
|
0.78
|
|
21
|
Multiplex PCR assay for the detection of mycobacterial DNA sequences directly from sputum.
|
In Vivo
|
1999
|
0.77
|
|
22
|
Relationship between iNOS expression and aortic cell proliferation and apoptosis in an elastase-induced model of aorta aneurysm and the effect of 1400 W administration.
|
Surgery
|
2005
|
0.76
|
|
23
|
c-mos immunoreactivity is an indicator of good prognosis in lung cancer.
|
Histopathology
|
2000
|
0.76
|
|
24
|
Cisplatin stimulates the expression from the human immunodeficiency virus long terminal repeat sequences in human fibroblasts.
|
Anticancer Drugs
|
1990
|
0.76
|
|
25
|
Relationship of the K-ras/c-mos expression patterns with angiogenesis in non-small cell lung carcinomas.
|
Mol Med
|
2001
|
0.76
|
|
26
|
Why is p53-inducible gene 3 rarely affected in cancer?
|
Oncogene
|
2010
|
0.75
|
|
27
|
Inducible h-ras gene-expression controlled by an allosterically regulated transactivator.
|
Oncol Rep
|
1994
|
0.75
|
|
28
|
Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis.
|
Lung Cancer
|
2000
|
0.75
|
|
29
|
Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by cis-platin.
|
Genet Anal Tech Appl
|
1990
|
0.75
|
|
30
|
Absence of mutations in the functional domains of the human MDM2 oncogene in non-small cell lung carcinomas.
|
Mutat Res
|
2000
|
0.75
|